Monitor Q3 2026 results for momentum continuation, particularly ISP revenue growth and potential sustained profitability. The company's debt reduction and expanding margins suggest improving fundamentals, but the small absolute revenue base and OTC listing warrant caution on valuation.
Price Chart
Executive Summary
QHSLab reported Q2 2026 unaudited results with revenue up 40.1% YoY to $847,490 and a swing to net income of $38,030 vs a loss of $52,958 in Q2 2025. Gross margins expanded to 69.6%, and ISP recurring revenue grew 86.4%. The company also substantially reduced interest expense by retiring convertible debt. While H1 2026 still shows a net loss of $(65,876), the improvement is significant for a micro-cap healthcare tech company.
Key Facts
- Q2 2026 total revenue $847,490, up 40.1% YoY from $605,446
- Q2 2026 net income $38,030 vs net loss of $52,958 in Q2 2025
- ISP recurring revenue grew 86.4% to $491,399 in Q2 2026
- Gross margin expanded to 69.6% from 65.9% YoY
- Interest expense declined 87.3% to $16,741 in H1 2026 due to debt retirement
- H1 2026 net loss improved ~50% to $(65,876) from $(132,567)
- Operating income increased to $45,245 in Q2 2026 from $11,526
Financial Impact
Revenue growth of 40% YoY in Q2 2026 ($242k increase), gross profit up 48% ($191k), and net income swing of +$91k from loss to profit.
Risk Factors
- Small revenue base ($847k quarterly) makes growth rates volatile
- OTCQB listing limits liquidity and institutional interest
- H1 2026 still shows net loss of $65,876; sustained profitability not yet proven
- Historical stock performance shows negative returns following positive filings
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-035749 |
| Exhibit: ex99-1.htm | 0001493152-26-035749 |
| Document: 0001493152-26-035749-index-headers.html | 0001493152-26-035749 |
| Document: 0001493152-26-035749-index.html | 0001493152-26-035749 |
| Document: 0001493152-26-035749.txt | 0001493152-26-035749 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 17, 2026 5w ago | SC 13G | $0.3500 $0.3100 | ▼ −11.43% | ▼ −12.88% | $0.3000 (−14.29%) |
Aug 3, 2026 12w ago | 8-K | $0.3690 $0.4000 | ▲ +8.40% | ▲ +7.16% | $0.3000 (−18.70%) |
Jun 17, 2026 18w ago | 8-K | $0.3500 $0.3170 | ▼ −9.43% | ▼ −11.01% | $0.3000 (−14.29%) |
May 26, 2026 21w ago | 8-K | $0.4640 $0.3020 | ▼ −34.91% | ▼ −32.97% | $0.3000 (−35.34%) |
Apr 21, 2026 26w ago | 8-K | $0.6790 $0.4500 | ▼ −33.73% | ▼ −38.64% | $0.3000 (−55.82%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers